Factors associated with mortality among patients with acute ST-elevation myocardial infarction (STEMI) receiving the thrombolytic drug (Streptokinase) in Khon Kaen Hospital

Authors

  • Sudhithep Duangsorn Khon Kaen Hospital
  • Usawadee Tharnphraisarn Khon Kaen Hospital

Keywords:

Acute STEMI, Streptokinase, Mortality Factors

Abstract

Objective : To identify prognostic factors of death among patients with acute STEMI who were treated with streptokinase at Khon Kaen Hospital.

Method : We conducted a cross-sectional analytical study, including patients with STEMI who received streptokinase at Khon Kaen Hospital between January 1, 2019, and December 31, 2021. We used univariable and multivariable logistic regression analysis to identify factors associated with death and reported them as crude odds ratio (OR), adjusted OR, and their 95% confidence intervals (95% CI).

Result : A total of 524 patients were studied, of whom 77.0% were male, with an average age of 63.2 ± 11.3 years. There were 41 (7.8%) deaths. Multivariate analysis identified that significant factors associated with mortality were female gender (Adj OR 6.25; 95% CI 2.00-20.00) and onset-to-needle time of 120-360 minutes (Adj OR 12.12; 95% CI 2.00-73.41).

Conclusion : Factors affecting the mortality of STEMI patients treated with streptokinase at Khon Kaen Hospital include female gender and an onset-to-needle time of 120-360 minutes.

References

world health organization. world health organization 2020, [Online]. [Accessed 3 june 2022]: Available from: https://www.worldlifeexpectancy.com/thailand-coronary-heart-disease.

ลิขิต ธนสมบัติ และคณะ. การศึกษาปัจจัยที่มีความสัมพันธ์กับผลการรักษาผู้ป่วยด้วยการทำการถ่างขยาย หลอดเลือดหัวใจผ่านทางผิวหนังในประเทศไทย แบบสหสถาบัน (Thai PCI Registry). กรุงเทพมหานคร : สมาคมแพทย์โรคหัวใจแห่งประเทศไทย ในพระบรมราชูปถัมภ์; 2563. หน้า 1-94. 3. สมาคมแพทย์โรคหัวใจแห่งประเทศไทยในพระบรมราชูปถัมภ์. แนวเวชปฏิบัติการดูแลรักษาผู้ป่วยภาวะหัวใจขาดเลือดเฉียบพลัน พ.ศ.2563. กรุงเทพมหานคร : สมาคมแพทย์โรคหัวใจแห่งประเทศไทย ในพระบรมราชูปถัมภ์; 2563.

กองโรคไม่ติดต่อ. กองโรคไม่ติดต่อ 18 january 2022. [Online]. [Accessed 3 june 2022]: Available from: http://www.thaincd.com/2016/mission/documents-detail.php?id=14220&tid=32&gid=1-020.

Alfredo Renilla, Manuel Barreiro, Vicente Barriales, Francisco Torres, Paloma Alvarez, & Jose L Lambert. Management and risk factors for mortality in very elderly patients with acute myocardial infarction. Geriatr Gerontol International. 2012; 13(1): 1-6.

Pajaree Mongkhon, Piyameth Dilokthornsakul, Kanokkorn Tepwang, Kannika Tapanya, Chompoonut Sopitprasan, Pitchapat Chaliawsin, & Surasak Saokaew. The effects of fibrinolytic before referring STEMI patients: A systematic review and meta-analysis. IJC Heart & Vasculature. 2017; 15: 9-14.

Chorchana Wichian, Thotsaporn Morasert, Thanapon Nilmoje,& Ply Chichareon. Prevalence and predictors associated with in-hospital mortality in acute ST segment elevation myocardial infarction after reperfusion therapy in developing country. CARDIOVASCULAR DIAGNOSIS & THERAPY. 2020; 10(5): 1264-1269.

Songsak Kiatchoosakun, Chaiyasith Wongwipaporn, & Burabha Pussadhamma. Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. heart asia. 2016; 8(2): 13-17.

MUHAMMAD SHAHID, MUHAMMAD IRFAN, RAO HASHIM IDREES, MUHAMMAD MAQSOOD, JAMSHAD LATIF, & QAMAR RAFIQ. In hospital Mortality and its Predictors among STEMI suffering patients treated with Streptokinase. Pakistan Journal of Medical & Health Sciences. 2019; 13(2): 314-318.

M. Ali, S. A. Lange, T. Wittlinger1, G. Lehnert1, A. G. Rigopoulos & M. Noutsias. In-hospital mortality after acute STEMI in patients undergoing primary PCI. Herz. 2017; 43: 741–745.

D. A. D. L. B. G. C. F. S. G. K. L. G. L. A. G. P. A. H. P. M. H. C. Y. J. M. L. K. D. J. K. S. P. Hani Jneid. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017; 70(16): pp. 2048–90.

Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999; 341(4): 217-225.

Downloads

Published

2024-12-24

How to Cite

Duangsorn, S., & Tharnphraisarn, U. . (2024). Factors associated with mortality among patients with acute ST-elevation myocardial infarction (STEMI) receiving the thrombolytic drug (Streptokinase) in Khon Kaen Hospital. Mahasarakham Hospital Journal, 21(3), 72–83. retrieved from https://he02.tci-thaijo.org/index.php/MKHJ/article/view/271076